Brigham and Women's Hospital investigators link very high lipoprotein(a) with a higher 30-year risk of major cardiovascular ...

A nearly 30-year study shows a strong long-term association between very high lipoprotein(a) levels and cardiovascular ...

Lipoprotein(a) levels greater 30 mg/dL linked to increased 30-year risk for major CV events and coronary heart disease.

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

Very high Lp(a) also correlated with higher risks of ischemic stroke and cardiovascular mortality in the Women’s Health Study ...

Contemporary guidelines do not generally endorse universal screening ...

As part of "heart health month," we're looking at lipoprotein (a). For decades, doctors have encouraged patients to monitor their cholesterol levels, with studies showing that heart disease risk ...

A new study finds that elevated levels of Lp(a) may increase the risk of death from cardiovascular disease in some patie ...

Low-density lipoprotein, known as LDL, is a complex structure with several components that allow cholesterol to circulate in the bloodstream, a watery environment. LDL is the primary mechanism used to ...

Every Australian adult should be screened for a potentially deadly type of inherited cholesterol, and if the simple blood ...